blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3833677

EP3833677 - IMPROVED RSV PASSIVE AND ACTIVE VACCINES [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  14.05.2021
Database last updated on 11.09.2024
FormerThe international publication has been made
Status updated on  15.02.2020
Most recent event   Tooltip14.06.2023New entry: Renewal fee paid 
Applicant(s)For all designated states
Trellis Bioscience, Inc.
702 Marshall Street, Suite 614
Redwood City, CA 94063 / US
[2022/03]
Former [2021/24]For all designated states
Trellis Bioscience, LLC
702 Marshall Street
Suite 614
Redwood City, CA 94063 / US
Inventor(s)01 / FRIEDMAN, Milton J.
2626 Santa Clara Avenue
Alameda, California 94501 / US
02 / KAUVAR, Lawrence M.
1438 Green Street, 7A
San Francisco, California 94109 / US
 [2021/24]
Representative(s)Hutter, Anton, et al
Venner Shipley LLP
5 Stirling House
Stirling Road The Surrey Research Park
Guildford GU2 7RF / GB
[2021/24]
Application number, filing date19847266.408.08.2019
[2021/24]
WO2019US45775
Priority number, dateUS201862716184P08.08.2018         Original published format: US 201862716184 P
[2021/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020033742
Date:13.02.2020
Language:EN
[2020/07]
Type: A1 Application with search report 
No.:EP3833677
Date:16.06.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 13.02.2020 takes the place of the publication of the European patent application.
[2021/24]
Search report(s)International search report - published on:US13.02.2020
(Supplementary) European search report - dispatched on:EP25.03.2022
ClassificationIPC:C07K16/10, C07K14/005, A61K39/395
[2022/17]
CPC:
C07K16/1027 (EP); A61K39/12 (US); A61K39/395 (EP);
A61P31/14 (US); C07K14/005 (EP); A61K2039/545 (US);
A61K2039/6056 (US); C07K2317/55 (EP); C07K2317/622 (EP);
C07K2317/76 (EP); C07K2317/92 (EP); C12N2760/18522 (EP);
C12N2760/18534 (EP) (-)
C-Set:
A61K39/395, A61K2300/00 (EP)
Former IPC [2021/24]C07K14/135, C07K16/28
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/24]
TitleGerman:VERBESSERTE RSV-PASSIVE UND -AKTIVE IMPFSTOFFE[2021/24]
English:IMPROVED RSV PASSIVE AND ACTIVE VACCINES[2021/24]
French:VACCINS PASSIFS ET ACTIFS AMÉLIORÉS CONTRE LE RSV[2021/24]
Entry into regional phase26.01.2021National basic fee paid 
26.01.2021Search fee paid 
26.01.2021Designation fee(s) paid 
26.01.2021Examination fee paid 
Examination procedure26.01.2021Examination requested  [2021/24]
16.11.2022Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
26.01.2023Amendment by applicant (claims and/or description)
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
26.01.2023Request for further processing filed
26.01.2023Full payment received (date of receipt of payment)
Request granted
03.02.2023Decision despatched
Fees paidRenewal fee
13.08.2021Renewal fee patent year 03
15.06.2022Renewal fee patent year 04
14.06.2023Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]WO2009055711  (TRELLIS BIOSCIENCE INC [US], et al) [I] 1-15 * throughout, in particular [0012]-[0015], examples 6-8, claims 1-5; [0044] *;
 [I]US2016145322  (WADIA JEHANGIR [US], et al) [I] 1-15 * throughout, e.g. [0008]-[0013] *;
 [XI]  - STANISLAV O. FEDECHKIN ET AL, "Structures of respiratory syncytial virus G antigen bound to broadly neutralizing antibodies", SCIENCE IMMUNOLOGY, (20180309), vol. 14, no. 21, doi:10.1126/sciimmunol.aar3534, page 1, XP055683672 [X] 1-4 * Throughout, e.g. Introduction, pg. 5, Fig. 1 * [I] 5-15

DOI:   http://dx.doi.org/10.1126/sciimmunol.aar3534
 [I]  - LEE YU-NA ET AL, "Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease", VIROLOGY, (20141230), vol. 476, doi:10.1016/J.VIROL.2014.12.004, ISSN 0042-6822, pages 217 - 225, XP029196545 [I] 1-15 * throughout, e.g. abstract, Results *

DOI:   http://dx.doi.org/10.1016/j.virol.2014.12.004
 [I]  - YOUNGJOO CHOI ET AL, "Antibodies to the Central Conserved Region of Respiratory Syncytial Virus (RSV) G Protein Block RSV G Protein CX3C-CX3CR1 Binding and Cross-Neutralize RSV A and B Strains", VIRAL IMMUNOLOGY, (20120502), doi:10.1089/vim.2011.0094, ISSN 0882-8245, XP055102546 [I] 1-15 * throughout, e.g. abstract, Pg. 194 right col., 197, 198 *

DOI:   http://dx.doi.org/10.1089/vim.2011.0094
 [I]  - SIMARD C ET AL, "EVIDENCE THAT THE AMINO ACID REGION 124-203 OF GLYCOPROTEIN G FROM THE RESPIRATORY SYNCYTIAL VIRUS (RSV) CONSTITUES A MAJOR PART OF THE POLYPEPTIDE DOMAIN THAT IS INVOLVED IN THE PROTECTION AGAINST RSV INFECTION", ANTIVIRAL RESEARCH, ELSEVIER BV, NL, (19950101), vol. 28, no. 4, doi:10.1016/0166-3542(95)00053-4, ISSN 0166-3542, pages 303 - 315, XP000565377 [I] 1-15 * throoughout, e.g. abstract, Results *

DOI:   http://dx.doi.org/10.1016/0166-3542(95)00053-4
International search[XY]US6077511  (LANGEDIJK JOHANNES PETRUS MARI [NL]) [X] 13 * entire document * [Y] 14, 15;
 [A]US2004096451  (YOUNG JAMES F [US], et al) [A] 1-11, 13-15* entire document *;
 [Y]US2013034564  (KAUVAR LAWRENCE M [US], et al) [Y] 4, 15 * entire document *;
 [A]US2013136759  (ANDERSON LARRY J [US], et al) [A] 1-11, 13-15 * entire document *;
 [XY]US2017121394  (VORA KALPIT A [US], et al) [X] 7-11 * entire document * [Y] 5, 6, 14;
 [XY]  - FEDECHKIN et al., "Structures of Respiratory Syncytial Virus G Antigen Bound to Broadly-Neutralizing Antibodies", Science Immunology, (20180309), vol. 3, no. 21, pages 1 - 14, XP055683672 [X] 1-3 * . entire document * [Y] 4-6

DOI:   http://dx.doi.org/10.1126/sciimmunol.aar3534
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.